Emerging DNA topoisomerase inhibitors as anticancer drugs

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.9, Iss.1, 2004-05, pp. : 105-133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs

Current Medicinal Chemistry, Vol. 17, Iss. 35, 2010-12 ,pp. : 4270-4290

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments of DNA Poisons - Human DNA Topoisomerase II Inhibitors - as Anticancer Agents

Current Pharmaceutical Design, Vol. 19, Iss. 13, 2013-04 ,pp. : 2474-2488

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of Catalytic Inhibitors of Human DNA Topoisomerase II As Novel Anticancer Agents

Current Medicinal Chemistry, Vol. 20, Iss. 5, 2013-02 ,pp. : 694-709

Bentham Science Publishers

Access to resources Recommend Favorite

Dual Topoisomerase I/II Poisons as Anticancer Drugs

By Denny W.A.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 12, 1997-12 ,pp. : 1845-1852

Informa Healthcare

Access to resources Recommend Favorite

Topoisomerase I Poisons and Suppressors as Anticancer Drugs

Current Medicinal Chemistry, Vol. 7, Iss. 1, 2000-01 ,pp. : 39-58

Bentham Science Publishers

Access to resources Recommend Favorite